QT Vascular Announces FDA Has Granted Approval to Initiate the Pivotal Trial of Its Novel Drug-Coated Balloon

News Conditional IDE approval allows the company to begin clinical study that is the next critical step in the U.S. regulatory path. Design of the pivotal study features first head-to-head randomization against another drug-coated balloon. Contributed Author:  QT Vascular Ltd. Topics:  Cardiovascular